
Dimerix shares plunged 35–40% amid heavy selling and uncertainty around clinical updates, worsened by weak biotech sentiment. Further downside depends on results and the funding outlook, though volatility in early-stage biotech stocks suggests a potential for sharp rebounds.

Resolution Minerals (ASX: RML) has rebounded from $0.04 toward $0.07–$0.08, driven by U.S. critical minerals progress and rising investor interest. Despite volatility, strong project developments, infrastructure moves, and drilling activity are shifting sentiment and supporting renewed momentum.

Acrow (ASX: ACF) is technically rebounding, balancing record revenue and strong industrial-access growth with falling margins and rising debt. Future performance depends on profitably converting its $256 million pipeline and breaking key resistance near $1.00.

Fleetwood Limited (ASX: FWD) is positioning itself as a major player in Australia’s modular construction and accommodation industry. Through its three divisions — Building Solutions, RV Solutions, and Community Solutions — the company has built a resilient, diversified business model capable of navigating cyclical shifts in housing, tourism, and resources.
.webp&w=828&q=75)
Brisbane Broncos (ASX: BBL) is an NRL franchise generating sports entertainment revenue. Its share price volatility stems from on-field performance, low liquidity, and solid earnings growth. Technically, the stock is currently testing key channel support around $1.25.

Wiseway is an integrated logistics provider spanning freight forwarding, warehousing, e-commerce fulfilment and perishables. Strong 1H26 revenue and earnings growth, US expansion and capital returns supported its share-price rally, while the recent pullback tests a technically significant support zone